3.
Pharceutical development
3-1.
Regulatory Bodies
Japan (PMDA/MHLW):
PMDA (
Pharmaceuticals and Medical Devices Agency
)
@
MHLW (
Ministry of Health, Labour and Welfare
)
US (
FDA
: Food and Drug Administration)
:
@@
Human Drugs
EU (CHMP: -EMA): EMA:@@
@@
European Medicines Agency
@CHMP:
Committee for Medicinal Products for Human Use
3-2.
Industry
Japan: JPMA:
Japan Pharmaceutical Manufacturers Association
@@@@
Office of Pharmaceutical Industry Research
@
US:
PhRMA:
Pharmaceutical Research and Manufacturers of America
:
PhRMA Japan
EU:
EFPIA: European Federation of Pharmaceutical Industries and Associations
@
EFPIA Japan
3-3.
Academia & Collaborations
ICH:
ICH Official Web Site
Japanese Society of Clinical Pharmacology and Therapeutics
(in Japanese)
American College of Clinical Pharmacology
Society for Regulatory Science of Medical Products
3-4. CROs closely related to Clinical Pharmacology
ICON
Cognigen
Certara
3-5. Interesting articles/meetings: (Link to another page)
Future directions for peptide therapeutics development
Draft agenda -EMA EFPIA Workshop on the importance of dose finding and dose selection for the successful development, licensing and lifecycle management of medicinal products 04?05 December 2014
,
30 Churchill Place, Canary Wharf, London E14 5EU:
TEACHING SAFE AND EFFECTIVE PRESCRIBING
@
IN UK MEDICAL SCHOOLS: A CORE CURRICULUM FOR TOMORROW'S DOCTORS.
Simon Maxw and Tom Walley, on behalf of the Clinical Section Committee of the British Pharmacological Society
Biologics, Biomarkers, Genomics and Proteomics Research: A Compilation of Sources
(Go back to Homej
(The latest modification on Apr. 7, 2019)